BACKGROUND: Breast cancer remains the second leading cause of cancer deaths for women in the United States. Screening with treatment has lowered breast cancer mortality. METHODS: Every 2 years, CDC uses Behavioral Risk Factor Surveillance System data to estimate mammography prevalence in the United States. Up-to-date mammography prevalence is calculated for women aged 50-74 years who report they had the test in the preceding 2 years. RESULTS: For 2008, overall, age-adjusted, up-to-date mammography prevalence for U.S. women aged 50-74 years was 81.1%, compared with 81.5% in 2006. Among the lowest prevalences reported were those by women aged 50-59 years (79.9%), persons who did not finish high school (72.6%), American Indian/Alaska Natives (70.4%), those with annual household income <$15,000 (69.4%), and those without health insurance (56.3%). Highest mammography prevalence was among residents of the northeastern United States. CONCLUSIONS: In recent years, mammography rates have plateaued. Critical gaps in screening remain for certain racial/ethnic groups and lower socioeconomic groups, and for the uninsured. IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Health-care reform is likely to increase access by increasing insurance coverage and by reducing out-of-pocket costs for mammography screening. Widespread implementation of evidence-based interventions also will be needed to increase screening rates. These include patient and provider reminders to schedule a mammogram, use of small media (e.g., videos, letters, brochures, and flyers), one-on-one education of women, and reduction of structural barriers (e.g., more convenient hours and attention to language, health literacy, and cultural factors).
BACKGROUND:Breast cancer remains the second leading cause of cancer deaths for women in the United States. Screening with treatment has lowered breast cancer mortality. METHODS: Every 2 years, CDC uses Behavioral Risk Factor Surveillance System data to estimate mammography prevalence in the United States. Up-to-date mammography prevalence is calculated for women aged 50-74 years who report they had the test in the preceding 2 years. RESULTS: For 2008, overall, age-adjusted, up-to-date mammography prevalence for U.S. women aged 50-74 years was 81.1%, compared with 81.5% in 2006. Among the lowest prevalences reported were those by women aged 50-59 years (79.9%), persons who did not finish high school (72.6%), American Indian/Alaska Natives (70.4%), those with annual household income <$15,000 (69.4%), and those without health insurance (56.3%). Highest mammography prevalence was among residents of the northeastern United States. CONCLUSIONS: In recent years, mammography rates have plateaued. Critical gaps in screening remain for certain racial/ethnic groups and lower socioeconomic groups, and for the uninsured. IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Health-care reform is likely to increase access by increasing insurance coverage and by reducing out-of-pocket costs for mammography screening. Widespread implementation of evidence-based interventions also will be needed to increase screening rates. These include patient and provider reminders to schedule a mammogram, use of small media (e.g., videos, letters, brochures, and flyers), one-on-one education of women, and reduction of structural barriers (e.g., more convenient hours and attention to language, health literacy, and cultural factors).
Authors: Lucy A Peipins; Jacqueline Miller; Thomas B Richards; Janet Kay Bobo; Ta Liu; Mary C White; Djenaba Joseph; Florence Tangka; Donatus U Ekwueme Journal: J Community Health Date: 2012-12
Authors: S Bryn Austin; Mathew J Pazaris; Lauren P Nichols; Deborah Bowen; Esther K Wei; Donna Spiegelman Journal: Cancer Causes Control Date: 2012-05-22 Impact factor: 2.506
Authors: Beverly B Green; Andy Bogart; Jessica Chubak; Sally W Vernon; Leo S Morales; Richard T Meenan; Sharon S Laing; Sharon Fuller; Cynthia Ko; Ching-Yun Wang Journal: Am J Prev Med Date: 2012-04 Impact factor: 5.043
Authors: Nancy Pandhi; Jennifer E DeVoe; Jessica R Schumacher; Christie Bartels; Carolyn T Thorpe; Joshua M Thorpe; Maureen A Smith Journal: J Am Board Fam Med Date: 2011 Jul-Aug Impact factor: 2.657